Delivery Order SPE2DE21D0005-SPE2D625F74K4

Award Date 12/12/24
Potential Completion Date 12/17/24
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F74K4
    Delivery Order

This federal contract award to Organogenesis Inc., a regenerative medicine company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order is for the supply of APLIGRAF, an advanced wound care product, to support military medical needs. The contract has a ceiling value of $1,239.95 and runs through December 17, 2024. While the award does not utilize a set-aside designation, Organogenesis has been the recipient of prior contracts through small business programs. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, demonstrating its strong presence in government medical procurement. These include a $25 million single-award IDC with the VA for surgical implants, a $30 million multiple-award Federal Supply Schedule contract with the VA for tissue regeneration products, and a $49.5 million multiple-award IDC with the DLA for wound care dressings and medical supplies.

Generated 3/13/25, 10:05 AM